Department of Critical Care, Beijing Lu He hospital, Capital Medical University, Beijing, People's Republic of China.
Int Wound J. 2023 Aug;20(6):1979-1986. doi: 10.1111/iwj.14059. Epub 2023 Jan 30.
Sepsis is a potentially lethal condition that occurs when the body's response to infection damages tissue and organs. The production of inflammatory mediators typically assists in defending the body against infection; however, an overreaction to inflammation can cause coagulation problems, vascular endothelial damage, and organ hypoperfusion. Blood purification methods, such as plasmapheresis, can effectively remove inflammatory mediators from plasma. The purpose of this meta-analysis was to explore the efficacy of plasma exchange for sepsis treatment as noted in recent studies. The authors searched the Pubmed (Medline), Cochrane Central Register of Controlled Trials (The Cochrane Library), Embase (Ovid), and Scopus databases and included controlled clinical studies that compared plasmapheresis or plasma filtration with conventional treatment in patients with severe sepsis. The Newcastle-Ottawa Scale literature quality assessment tool was used to assess the risk of bias. The primary study outcome was all-cause mortality. The random effects model was adopted for conducting the meta-analysis. Among the 1013 records found, the study included 5 trials, all of which carried a low risk of bias. The use of plasmapheresis was associated with a longer stay in the intensive care unit (odds ratio [OR], 0.85, 95% confidence interval [CI], 0.39-1.32, heterogeneity [I ] = 0%), a significant reduction in all-cause mortality (OR, 0.54, 95% CI, 0.33-0.89, I = 70%), and reduced mortality (OR, 0.29, 95% CI, 0.13-0.67, I = 0%) in adults; the results for children differed from this (OR, 0.79, 95% CI, 0.36-1.72, I = 89%). Four trials reported no adverse events; one trial reported an adverse event related to plasma exchange, including an instance of hypotension in one patient. Plasmapheresis appeared to be an effective treatment for patients suffering from sepsis. A large number of additional randomised controlled trials are needed to confirm this finding.
脓毒症是一种潜在的致命疾病,当身体对感染的反应损害组织和器官时就会发生。炎症介质的产生通常有助于身体抵抗感染;然而,炎症的过度反应会导致凝血问题、血管内皮损伤和器官灌注不足。血液净化方法,如血浆置换,可以有效地从血浆中去除炎症介质。本荟萃分析的目的是探讨最近研究中提到的血浆置换治疗脓毒症的疗效。作者检索了 Pubmed(Medline)、Cochrane 中心对照试验注册库(Cochrane 图书馆)、Embase(Ovid)和 Scopus 数据库,并纳入了比较严重脓毒症患者血浆置换或血浆滤过与常规治疗的对照临床试验。采用纽卡斯尔-渥太华量表文献质量评估工具评估偏倚风险。主要研究结局为全因死亡率。采用随机效应模型进行荟萃分析。在 1013 条记录中,研究纳入了 5 项试验,所有试验的偏倚风险均较低。使用血浆置换与 ICU 住院时间延长(比值比 [OR],0.85,95%置信区间 [CI],0.39-1.32,异质性 [I ]=0%)、全因死亡率显著降低(OR,0.54,95%CI,0.33-0.89,I=70%)和降低死亡率(OR,0.29,95%CI,0.13-0.67,I=0%)相关,成人结果与儿童结果不同(OR,0.79,95%CI,0.36-1.72,I=89%)。四项试验未报告不良事件;一项试验报告了与血浆置换相关的不良事件,包括一名患者出现低血压。血浆置换似乎是治疗脓毒症患者的有效方法。需要更多的随机对照试验来证实这一发现。